Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleroderma in childhood.

B H Singsen

    Pediatric Clinics of North America
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Scleroderma in children presents diverse forms, from mild skin issues to severe organ damage. Outcomes depend on disease extent, disfigurement, and available treatments for this rare condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sarcoidosis and systemic vasculitis.

    Seminars in arthritis and rheumatism·2000
    Same author

    Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders.

    Rheumatic diseases clinics of North America·1997
    Same author

    Emergency and critical care issues in pediatric rheumatology.

    Rheumatic diseases clinics of North America·1997
    Same author

    Physical fitness in children with juvenile rheumatoid arthritis and other chronic pediatric illnesses.

    Pediatric clinics of North America·1995
    Same author

    Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate.

    Annals of the rheumatic diseases·1994
    Same author

    Reflex sympathetic dystrophy in children: an orthopedic perspective.

    Orthopedics·1993
    Same journal

    Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

    Pediatric clinics of North America·2026
    Same journal

    Advancing Pediatric Dermatology: Innovations in Care and Access.

    Pediatric clinics of North America·2026
    Same journal

    No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

    Pediatric clinics of North America·2026
    Same journal

    Telemedicine and Access to Pediatric Dermatology Care.

    Pediatric clinics of North America·2026
    Same journal

    Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

    Pediatric clinics of North America·2026
    Same journal

    Medical Photography's Power to Change Medical Care.

    Pediatric clinics of North America·2026
    See all related articles

    Area of Science:

    • Pediatric rheumatology
    • Dermatology
    • Rare diseases

    Background:

    • Scleroderma is a rare autoimmune disease affecting children.
    • It exhibits significant heterogeneity in clinical presentation and severity.
    • Manifestations range from localized skin changes to systemic organ involvement.

    Purpose of the Study:

    • To summarize the varied clinical spectrum of childhood scleroderma.
    • To highlight factors influencing patient outcomes.
    • To underscore the importance of early diagnosis and management.

    Main Methods:

    • Review of existing literature on pediatric scleroderma.
    • Analysis of clinical case studies.
    • Synthesis of data on disease progression and treatment responses.

    Related Experiment Videos

    Main Results:

    • Childhood scleroderma presents a wide range of clinical forms.
    • Outcomes are influenced by the extent and location of skin and internal organ involvement.
    • Disfigurement, functional impairment, and access to treatment resources significantly impact prognosis.

    Conclusions:

    • Pediatric scleroderma requires individualized management strategies.
    • Prognosis is variable and depends on a complex interplay of disease factors.
    • Multidisciplinary care is essential for optimizing outcomes in affected children.